offline
Johnson & Johnson (JNJ) Surpasses Q4 Earnings Estimates
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $2.12 per share. This compares to earnings of $1.86 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 0.47%. A quarter ago, it was expected that this world's biggest maker of health care products would post earnings of $2.37 per share when it actually produced earnings of $2.60, delivering a surprise of 9.70%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Johnson & Johnson , which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $24.8 billion for the quarter ended December 2021, missing the Zacks Consensus Estimate by 1.77%. This compares to year-ago revenues of $22.48 billion.
...
https://finance.yahoo.com/news/johnson-j...12495.html
![[Bild: JNJw053513966i.png]](https://finviz.com/publish/012722/JNJw053513966i.png)
Johnson & Johnson (JNJ) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $2.12 per share. This compares to earnings of $1.86 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 0.47%. A quarter ago, it was expected that this world's biggest maker of health care products would post earnings of $2.37 per share when it actually produced earnings of $2.60, delivering a surprise of 9.70%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Johnson & Johnson , which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $24.8 billion for the quarter ended December 2021, missing the Zacks Consensus Estimate by 1.77%. This compares to year-ago revenues of $22.48 billion.
...
https://finance.yahoo.com/news/johnson-j...12495.html
__________________
